This study aims at assessing the efficacy of improving skin aging signs of a serum containing collagen 16 combined with a biostimulation device in healthy female subjects aged between 30 and 70 years over a period of 13 weeks.
Female trial participants aged from 30 to 70 years.
Trial participants who are regular users of anti-aging cosmetic products.
Wrinkle visibility score ≥3 and ≤6 on a 10-point visual scale.
Fine lines visibility score ≥3 and ≤6 on a 10-point visual scale.
Trial participants who are pregnant, breastfeeding, or planning to become pregnant during the study period.
Trial participants who are currently participating in another facial clinical study or who have participated in such a study within 1 month that may interfere with the study outcomes.
Trial participants presenting with current flaring or severe inflammatory acne or any active dermatological condition that, in the investigator's opinion, could interfere with study assessments.
Trial participants who have undergone ablative laser treatments, microneedling, chemical peels, dermabrasion, non-ablative laser, intense pulsed light (IPL), or injectable procedures within the last 12 months from the day of screening.